ABCC4 is required for cell proliferation and tumorigenesis in non-small cell lung cancer

Xiaoting Zhao1, Yinan Guo1, Wentao Yue1

  • 1Department of Cellular and Molecular Biology, Beijing TB and Thoracic Tumor Research Institute/Beijing Chest Hospital, Capital Medical University, Beijing, People's Republic of China.

Abstract

Insights

Multidrug resistance protein 4 (MRP4/ABCC4) is highly expressed in lung cancer cells and drives proliferation. Inhibiting ABCC4 suppresses lung cancer cell growth and may offer a new therapeutic target.

Area of Science:

  • Molecular biology
  • Cancer research
  • Cell biology

Background:

  • Multidrug resistance protein 4 (MRP4), also known as ATP-cassette binding protein 4 (ABCC4), is an ATP-binding cassette transporter involved in drug efflux.
  • The specific role of ABCC4 in lung cancer cell proliferation remains largely uncharacterized.

Purpose of the Study:

  • To investigate the expression and function of ABCC4 in lung cancer cell proliferation.
  • To determine if ABCC4 could serve as a therapeutic target for lung cancer.

Main Methods:

  • Quantitative real-time PCR and Western blotting were used to assess ABCC4 mRNA and protein levels in lung cancer cell lines and patient tissues.
  • Lentivirus-mediated RNA interference was employed to suppress ABCC4 expression in A549 and 801D cells.
  • Cell proliferation was evaluated using MTS and colony formation assays, while cell cycle progression was analyzed by flow cytometry and Western blotting.

Main Results:

  • ABCC4 was found to be highly expressed in lung cancer cell lines and patient tumor tissues.
  • Suppression of ABCC4 expression using RNA interference led to inhibited cell growth in A549 and 801D cells.
  • Downregulation of ABCC4 resulted in an increased percentage of cells in the G1 phase and weakened retinoblastoma protein phosphorylation, indicating cell cycle arrest.

Conclusions:

  • ABCC4 plays a significant role in regulating the proliferation of lung cancer cells.
  • ABCC4 represents a promising molecular target for the development of novel lung cancer therapies.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
3.7K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K